首页 | 本学科首页   官方微博 | 高级检索  
     

血清IL-17A与干扰素γ诱导蛋白10在原发性肝癌中的表达及临床意义
引用本文:李 玮,谢友利,刘雅娟,吴兰梅. 血清IL-17A与干扰素γ诱导蛋白10在原发性肝癌中的表达及临床意义[J]. 现代肿瘤医学, 2021, 0(18): 3228-3232. DOI: 10.3969/j.issn.1672-4992.2021.18.019
作者姓名:李 玮  谢友利  刘雅娟  吴兰梅
作者单位:武汉大学中南医院肝胆胰腺外科,湖北 武汉 430071
摘    要:
目的:探讨血清IL-17A与干扰素γ诱导蛋白10(IP-10)在原发性肝癌中的表达及临床意义.方法:收集2015年1月至2017年12月我科收治的原发性肝癌患者182例(实验组)及健康体检者50例(对照组),检测两组受试者血清IL-17A、IP-10值,比较两组血清IL-17A、IP-10水平差异,分析血清IL-17A...

关 键 词:白细胞介素-17A  干扰素γ诱导蛋白10  肝癌

Expression of serum IL-17A and interferon gamma-inducible protein 10 in primary liver cancer and its clinical significance
LI Wei,XIE Youli,LIU Yajuan,WU Lanmei. Expression of serum IL-17A and interferon gamma-inducible protein 10 in primary liver cancer and its clinical significance[J]. Journal of Modern Oncology, 2021, 0(18): 3228-3232. DOI: 10.3969/j.issn.1672-4992.2021.18.019
Authors:LI Wei  XIE Youli  LIU Yajuan  WU Lanmei
Affiliation:Hepatobiliary and Pancreatic Surgery,Central South Hospital of Wuhan University,Hubei Wuhan 430071,China.
Abstract:
Objective:To investigate the expression and clinical significance of serum IL-17A and interferon gamma-inducible protein 10 (IP-10) in primary liver cancer.Methods:A total of 182 patients with primary liver cancer (experimental group) and 50 healthy subjects (control group) were enrolled from January 2015 to December 2017.The serum levels of IL-17A and IP-10 were detected in the two groups.The difference of serum IL-17A and IP-10 levels between the two groups was compared,and the predictive value of serum IL-17A and IP-10 for early diagnosis of primary liver cancer was analyzed.Results:The preoperative levels of serum IL-17A,IP-10 in the experimental group was higher than that of serum IL-17A and IP-10 in the control group (P<0.05).The postoperative levels of serum IL-17A and IP-10 in the experimental group were lower than those preoperative levels of serum IL-17A and IP-10 in the experimental group (P<0.05).There were significant differences in serum IL-17A and IP-10 levels between different pathological tissue types of patients with primary liver cancer (P<0.05).The levels of serum IL-17A and IP-10 in stage Ⅲ of primary liver cancer were higher than that of serum IL-17A and IP-10 in stage Ⅰ and Ⅱ of patients with primary liver cancer (P<0.05).Multivariate analysis showed that elevated serum TBil,AST,ALT,AFP,IL-17A,and IP-10 levels were indenpendent risk factors for primary liver cancer.The ROC curve showed that the area under the serum IL-17A curve was 0.793,and the sensitivity and specificity were 0.827 and 0.619,respectively.The area under the IP-10 curve was 0.757,and the sensitivity and specificity were 0.796 and 0.714,respectively.The area under the serum IL-17A combined with IP-10 was 0.883,and the sensitivity and specificity were 0.898 and 0.810,respectively.Conclusion:The elevated levels of serum IL-17A and IP-10 play an important role in the progression of primary liver cancer,and can be used as one of the early diagnostic indicators for primary liver cancer.
Keywords:interleukin-17A   interferon gamma-inducible protein 10   liver cancer
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号